Showing results (11-20 of 203) with videos related to
Sort By:
Pageof 21
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
HIV-2 antiviral potency and selection of drug resistance mutations by the integrase strand transfer inhibitor elvitegravir and NRTIs emtricitabine and tenofovir in vitroKristen Andreatta, Michael D Miller, Kirsten L WhiteAntiviral Research|December 27, 2016
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitroYang Liu, Michael D Miller, Kathryn M KitrinosAntimicrobial Agents and Chemotherapy|June 19, 2002
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptaseLisa K Naeger, Nicolas A Margot, Michael D MillerAIDS (London, England)|April 7, 2007
Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RTBrandi J Chappell, Nicolas A Margot, Michael D MillerAntimicrobial Agents and Chemotherapy|March 24, 2010
Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimatNicolas A Margot, Craig S Gibbs, Michael D MillerAntimicrobial Agents and Chemotherapy|July 8, 2015
In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil FumarateChristian Callebaut, George Stepan, Yang Tian, et al.Antimicrobial Agents and Chemotherapy|November 18, 2015
Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance SubstitutionsKristen N Andreatta, Michael D Miller, Kirsten L WhiteOrthopedics|April 2, 2014
Isolated Lactobacillus chronic prosthetic knee infectionDavid M Bennett, Tatyana Shekhel, Matt Radelet, et al.Antimicrobial Agents and Chemotherapy|July 8, 2015
Characterization of HIV-1 Resistance to Tenofovir Alafenamide In VitroNicolas A Margot, Audun Johnson, Michael D Miller, et al.Antiviral Research|May 22, 2016
High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarateNicolas A Margot, Yang Liu, Michael D Miller, et al.Pageof 21